Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: A pilot open‐label study
暂无分享,去创建一个
P. Krystkowiak | A. Kreisler | Luc Defebvre | Alain Destée | Louise Tyvaert | François Cassim | Elise Houdayer
[1] J. Morris,et al. Validity and Reliability of the Alzheimer's Disease Cooperative Study‐Clinical Global Impression of Change , 2017 .
[2] Janneke Koerts,et al. Cognitive dysfunction in non-demented Parkinson's disease patients: Controlled and automatic behavior , 2009, Cortex.
[3] W D Heiss,et al. STN-DBS activates the target area in Parkinson disease , 2008, Neurology.
[4] Didier Hannequin,et al. Microsubthalamotomy: An immediate predictor of long‐term subthalamic stimulation efficacy in Parkinson disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[5] T. Robbins,et al. Similar Effects of the Selective Noradrenaline Reuptake Inhibitor Atomoxetine on Three Distinct Forms of Impulsivity in the Rat , 2008, Neuropsychopharmacology.
[6] T. Robbins,et al. Atomoxetine Improved Response Inhibition in Adults with Attention Deficit/Hyperactivity Disorder , 2007, Biological Psychiatry.
[7] S. Ochudło,et al. Various patterns of gestes antagonistes in cervical dystonia. , 2007, Parkinsonism & related disorders.
[8] H. Shill,et al. Defining mild cognitive impairment in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[9] T. Robbins,et al. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. , 2007, Brain : a journal of neurology.
[10] M. Hallett,et al. Abnormality of motor cortex excitability in peripherally induced dystonia , 2007, Movement disorders : official journal of the Movement Disorder Society.
[11] B. Bloem,et al. Evidence‐based analysis of physical therapy in Parkinson's disease with recommendations for practice and research , 2007, Movement disorders : official journal of the Movement Disorder Society.
[12] B. Bloem,et al. Effectiveness of physiotherapy in Parkinson's disease: the feasibility of a randomised controlled trial. , 2007, Parkinsonism & related disorders.
[13] C. Bjarkam,et al. Chronic subthalamic high‐frequency deep brain stimulation in Parkinson's disease – a histopathological study , 2007, European journal of neurology.
[14] G. Kwakkel,et al. Cueing training in the home improves gait-related mobility in Parkinson’s disease: the RESCUE trial , 2007, Journal of Neurology, Neurosurgery & Psychiatry.
[15] Claire Ballinger,et al. A randomised controlled trial of a home based exercise programme to reduce the risk of falling among people with Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[16] L. Defebvre,et al. Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[17] Dieter Vaitl,et al. Training of executive functions in Parkinson's disease , 2006, Journal of the Neurological Sciences.
[18] E. Rochtchina,et al. Prevalence of mitochondrial DNA haplogroups in an Australian population , 2006, Internal medicine journal.
[19] A. Berardelli,et al. Botulinum toxin changes intrafusal feedback in dystonia: A study with the tonic vibration reflex , 2006, Movement disorders : official journal of the Movement Disorder Society.
[20] G. Deuschl,et al. Deep brain stimulation: Postoperative issues , 2006, Movement disorders : official journal of the Movement Disorder Society.
[21] T. Robbins,et al. Neurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans , 2006, Science.
[22] K. Perry,et al. Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine , 2006, Molecular Psychiatry.
[23] F. Pierelli,et al. Myoclonus of the scapula after acute long thoracic nerve lesion: A case report , 2006, Movement disorders : official journal of the Movement Disorder Society.
[24] S. Faraone,et al. Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorder. , 2005, Journal of child and adolescent psychopharmacology.
[25] V. Álvarez,et al. Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population , 2005, Journal of the Neurological Sciences.
[26] Rajesh Pahwa,et al. Preoperative Clinical Predictors of Response to Bilateral Subthalamic Stimulation in Patients with Parkinson’s Disease , 2005, Stereotactic and Functional Neurosurgery.
[27] N. Van Blercom,et al. Efficacy and Safety of Donepezil in the Treatment of Executive Dysfunction in Parkinson Disease: A Pilot Study , 2005, Clinical neuropharmacology.
[28] M. T. Pellecchia,et al. Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians , 2005, European Journal of Human Genetics.
[29] S. Lewis,et al. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD , 2005, Annals of neurology.
[30] M. Schieppati,et al. Neck proprioception and spatial orientation in cervical dystonia. , 2004, Brain : a journal of neurology.
[31] J. Caviness,et al. Myoclonus: current concepts and recent advances , 2004, The Lancet Neurology.
[32] J. Krauss,et al. Movement disorders after intervertebral disc surgery: Coincidence or causal relationship? , 2004, Movement disorders : official journal of the Movement Disorder Society.
[33] M. Trimble,et al. The syndrome of fixed dystonia: an evaluation of 103 patients. , 2004, Brain : a journal of neurology.
[34] P. Kelly,et al. Location of the active contact within the subthalamic nucleus (STN) in the treatment of idiopathic Parkinson's disease. , 2004, Surgical neurology.
[35] Matthew B. Stern,et al. Bilateral Stimulation of the Subthalamic Nucleus in Parkinson’s Disease: Surgical Efficacy and Prediction of Outcome , 2004, Stereotactic and Functional Neurosurgery.
[36] J. Bogousslavsky,et al. Segmental dystonia induced by wearing glasses with a ribbon: An unusual case of a reverse sensory geste , 2004, Movement disorders : official journal of the Movement Disorder Society.
[37] W. Otten,et al. A system of networks and continuing education for physical therapists in rheumatology: a feasibility study , 2004, International journal of integrated care.
[38] Bastiaan R. Bloem,et al. Physiotherapy in Parkinson’s disease: utilisation and patient satisfaction , 2004, Journal of Neurology.
[39] H. Soininen,et al. Mitochondrial DNA polymorphisms as risk factors for Parkinson’s disease and Parkinson’s disease dementia , 2004, Human Genetics.
[40] M. Naumann,et al. Complex mechanisms of sensory tricks in cervical dystonia , 2004, Movement disorders : official journal of the Movement Disorder Society.
[41] E. Bézard,et al. High‐frequency stimulation of both zona incerta and subthalamic nucleus induces a normalization of basal ganglia metabolic activity in experimental parkinsonism , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[42] A. Berardelli,et al. Central effects of botulinum toxin type A: Evidence and supposition , 2004, Movement disorders : official journal of the Movement Disorder Society.
[43] K. Aoki,et al. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain , 2004, Pain.
[44] Y. Agid,et al. Parkinson's disease, subthalamic stimulation, and selection of candidates: A pathological study , 2003, Movement disorders : official journal of the Movement Disorder Society.
[45] G. Kennedy. STAGED, STAR*D, and PROSPECT Compared: Guidelines for the Pharmacologic Treatment of Late-Life Depression in Primary Care , 2003 .
[46] C. Clarke,et al. A Delphi Survey of Best Practice Occupational Therapy for Parkinson's Disease in the United Kingdom , 2003 .
[47] K. Macey. Conners' Adult ADHD Rating Scales (CAARS). , 2003 .
[48] Hon-Man Liu,et al. Treatment of advanced Parkinson's disease by subthalamotomy: One‐year results , 2003, Movement disorders : official journal of the Movement Disorder Society.
[49] Y. Agid,et al. Subthalamic stimulation in Parkinson disease: intraoperative predictive factors. , 2003, Archives of neurology.
[50] P. Stanzione,et al. Pramipexole in comparison to l-dopa: a neuropsychological study , 2003, Journal of Neural Transmission.
[51] D. Middleton,et al. mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish , 2003, Experimental Gerontology.
[52] J. Haines,et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. , 2003, American journal of human genetics.
[53] S. West,et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies , 2003, Biological Psychiatry.
[54] A. Tröster,et al. Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson’s disease , 2003, Journal of the International Neuropsychological Society.
[55] Y. Ben-Shlomo,et al. Systematic review of paramedical therapies for Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.
[56] Marjan Jahanshahi,et al. Clinical features of the geste antagoniste in cervical dystonia. , 2002, Advances in neurology.
[57] Herta Flor,et al. Phantom-limb pain: characteristics, causes, and treatment , 2002, The Lancet Neurology.
[58] Jens Volkmann,et al. Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position. , 2002, Journal of neurosurgery.
[59] J. Nutt,et al. Methylphenidate Increases the Motor Effects of L-Dopa in Parkinson's Disease: A Pilot Study , 2001, Clinical neuropharmacology.
[60] W. Poewe,et al. Clinical characteristics of the geste antagoniste in cervical dystonia , 2001, Journal of Neurology.
[61] Y. Ben-Shlomo,et al. Non-pharmacological therapies for dysphagia in Parkinson's disease. , 2001, The Cochrane database of systematic reviews.
[62] W. Weiner. Can peripheral trauma induce dystonia? No! , 2001, Movement disorders : official journal of the Movement Disorder Society.
[63] J. Jankovic. Can peripheral trauma induce dystonia and other movement disorders? Yes! , 2001, Movement disorders : official journal of the Movement Disorder Society.
[64] J. Obeso,et al. Dorsal subthalamotomy for Parkinson's disease , 2001, Movement disorders : official journal of the Movement Disorder Society.
[65] J. Ahlskog,et al. Focal shoulder‐elevation dystonia , 2000, Movement disorders : official journal of the Movement Disorder Society.
[66] M. Hallett,et al. Electrophysiological studies of myoclonus , 2000, Muscle & nerve.
[67] Karlheinz Reiners,et al. Sensory tricks in cervical dystonia: Perceptual dysbalance of parietal cortex modulates frontal motor programming , 2000, Annals of neurology.
[68] S. Fahn,et al. Focal task‐specific dystonia induced by peripheral trauma , 2000, Movement disorders : official journal of the Movement Disorder Society.
[69] M. Jahanshahi. Factors that ameliorate or aggravate spasmodic torticollis , 2000, Journal of neurology, neurosurgery, and psychiatry.
[70] W. Poewe,et al. Trick maneuvers in cervical dystonia: Investigation of movement‐ and touch‐related changes in polymyographic activity , 1999, Movement disorders : official journal of the Movement Disorder Society.
[71] S. Faraone,et al. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. , 1998, The American journal of psychiatry.
[72] M. Magistris,et al. Post-traumatic stimulus suppressible myoclonus of peripheral origin , 1998, Journal of neurology, neurosurgery, and psychiatry.
[73] S. Bressman,et al. Exteroceptive and interoceptive stimuli in dystonia , 1998, Movement disorders : official journal of the Movement Disorder Society.
[74] H. Soininen,et al. Reduction of noradrenaline impairs attention and dopamine depletion slows responses in Parkinson's disease , 1998, The European journal of neuroscience.
[75] R. Burke,et al. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. , 1998, Brain : a journal of neurology.
[76] Y. Agid,et al. Attentional deficits in Parkinson's disease: partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic alpha 1 agonist. , 1998, Clinical neuropharmacology.
[77] D. Kömpf,et al. Peripheral myoclonus due to spinal root lesion , 1997, Muscle & nerve.
[78] Bernard Pillon,et al. Cognitive deficits in Parkinson’s disease , 1996, Journal of Neurology.
[79] F. Glocker,et al. Bilateral myoclonus of the trapezius muscles after distal lesion of an accessory nerve , 1996, Movement disorders : official journal of the Movement Disorder Society.
[80] J. Speelman,et al. Quality of life in patients with Parkinson's disease: development of a questionnaire. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[81] P. Mitchell,et al. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. , 1996, Ophthalmology.
[82] C. Clarke,et al. QUALITY OF LIFE AND CARE IN PARKINSON'S DISEASE , 1995, The British journal of clinical practice.
[83] M. Mega,et al. The Neuropsychiatric Inventory , 1994, Neurology.
[84] C. Marsden,et al. The behavioural and motor consequences of focal lesions of the basal ganglia in man. , 1994, Brain : a journal of neurology.
[85] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[86] G. Deuschl,et al. Tremor in reflex sympathetic dystrophy. , 1991, Archives of neurology.
[87] J. Jankovic,et al. Dystonia and tremor induced by peripheral trauma: predisposing factors. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[88] C. Grassi,et al. Action of the sympathetic system on skeletal muscle , 1988, The Italian Journal of Neurological Sciences.
[89] U. Ahlfors,et al. The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients , 1987, Acta psychiatrica Scandinavica. Supplementum.
[90] A W Downie,et al. Parkinson's disease: disability, review, and management. , 1986, British medical journal.
[91] A. Eisen,et al. DOUBLE-BLIND STUDY OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLIS , 1986, The Lancet.
[92] G. Chouinard,et al. A case of mania associated with tomoxetine. , 1985, The American journal of psychiatry.
[93] M. Short,et al. Brachial plexus myoclonus. , 1985, Journal of Neurology Neurosurgery & Psychiatry.
[94] R. Mayeux,et al. Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism. , 1984, Archives of neurology.
[95] C. Marsden,et al. Muscle spasms associated with Sudeck's atrophy after injury. , 1984, British medical journal.
[96] N. Bathien,et al. [Rhythmic quadriceps myoclonia related to sarcomatous involvement of the crural nerve]. , 1977, Revue neurologique.
[97] J. Henry,et al. Effects of substance P on functionally identified units in cat spinal cord , 1976, Brain Research.
[98] S. Folstein,et al. “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .
[99] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[100] Bourdillon Jf. PHENOTHIAZINE DYSKINESIA AFTER LEUCOTOMY. , 1964, Lancet.
[101] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[102] B. Bloem,et al. Allied health care interventions and complementary therapies in Parkinson's disease. , 2007, Parkinsonism & related disorders.
[103] N. van Alfen,et al. The clinical spectrum of neuralgic amyotrophy in 246 cases. , 2006, Brain : a journal of neurology.
[104] M. Hallett,et al. Pathophysiology of dystonia. , 2006, Journal of neural transmission. Supplementum.
[105] G Polo,et al. Subthalamic nucleus stimulation in Parkinson's disease : anatomical and electrophysiological localization of active contacts. , 2006, Journal of neurology.
[106] J. Wernicke,et al. Cardiovascular Effects of Atomoxetine in Children, Adolescents, and Adults , 2003, Drug safety.
[107] C. Tomlinson,et al. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease. , 2001 .
[108] A. Bonnet,et al. [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.
[109] S. Gilman,et al. Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.
[110] J. Morris,et al. Validity and Reliability of the Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC) , 1997 .
[111] S H Ferris,et al. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. , 1997, Alzheimer disease and associated disorders.
[112] W. Brouwer,et al. Training of compensational strategies for impaired gross motor skills in Parkinson's disease , 1995 .
[113] S. Salloway,et al. Treatment strategies for patients with dysexecutive syndromes. , 1994, The Journal of neuropsychiatry and clinical neurosciences.
[114] P. Thompson,et al. Unusual focal dyskinesias: The ears, the shoulders, the back, and the abdomen , 1994, Movement disorders : official journal of the Movement Disorder Society.
[115] D. Brooks,et al. Core assessment program for intracerebral transplantations (CAPIT) , 1992, Movement disorders : official journal of the Movement Disorder Society.
[116] B. Reisberg. Functional assessment staging (FAST). , 1988, Psychopharmacology bulletin.
[117] S. Fahn. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .
[118] M. Hallett,et al. The nosology and pathophysiology of myoclonus , 1981 .
[119] E. Mancall,et al. Painful jumping amputation stumps: pathophysiology of a "sore circuit". , 1974, Transactions of the American Neurological Association.
[120] Mancall El,et al. Painful jumping amputation stumps: pathophysiology of a "sore circuit". , 1974 .
[121] B. Djahanguiri,et al. The prevention of acute gastric ulcer in the rat by alpha-methyldopa. , 1967, Medicina et pharmacologia experimentalis. International journal of experimental medicine.